Related Experiment Video
Updated: Aug 10, 2026

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
Rotavirus infection as cause of tacrolimus elevation in solid-organ-transplanted children
M Frühwirth1, H Fischer, B Simma
1Department of Pediatrics, Department of Transplantation Surgery, School of Medicine, University of Innsbruck, Anichstrasse 356, A-6020 Innsbruck, Austria. Martin.Fruehwirth@uibk.ac.at
Abstract:
Rotavirus (RV) is the most common cause of diarrheal illness in children. We report three solid-organ-transplanted patients in whom RV infection caused increased trough levels of the immunosuppressive macrolide tacrolimus (TAC) by mechanisms that are still under investigation. The virus was detected for longer in the feces of these patients than in infants not receiving immunosuppressive therapy. In association with short-term monitoring of blood trough levels of TAC, the dosage should be reduced early if symptoms of an acute gastroenteritis are present.
Insights
Rotavirus (RV) infection can increase tacrolimus (TAC) levels in organ transplant recipients. Early reduction of TAC dosage is recommended during acute gastroenteritis in these patients.
Area of Science:
- Immunology
- Virology
- Pharmacology
Background:
- Rotavirus (RV) is a leading cause of diarrheal illness in pediatric populations.
- Solid-organ transplant (SOT) recipients require immunosuppressive therapy, such as tacrolimus (TAC), to prevent rejection.
- Understanding drug-interactions in immunocompromised patients is crucial for effective management.
Observation:
- Three SOT patients experienced elevated tacrolimus (TAC) trough levels during rotavirus (RV) infection.
- RV was detected in feces for extended periods in these immunosuppressed patients compared to non-immunosuppressed infants.
- The precise mechanisms driving TAC level increases during RV infection remain under investigation.
Findings:
- Rotavirus infection is associated with significantly increased blood trough levels of tacrolimus in solid-organ transplant recipients.
- Persistent fecal shedding of RV observed in transplant patients suggests altered viral kinetics under immunosuppression.
- The study highlights a potential drug-virus interaction impacting tacrolimus pharmacokinetics.
Implications:
- Close monitoring of tacrolimus (TAC) blood trough levels is essential in solid-organ transplant recipients presenting with acute gastroenteritis.
- Prompt dosage reduction of TAC may be necessary to prevent toxicity during rotavirus infections.
- Further research is warranted to elucidate the mechanisms behind rotavirus-induced alterations in tacrolimus metabolism or transport.
Related Concept Videos
Cytomegalovirus Disease
Respiratory Syncytial Virus Disease

